ORPHA:300298
Severe congenital hypochromic anemia with ringed sideroblasts
Also known as: Severe congenital hypochromic sideroblastic anemia
Publications
2
1.9th percentile
Trials
0
Interventional, condition-specific
Researchers
25
Distinct authors in sample
Gene link
STEAP3
Moderate
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A very rare severe non-syndromic hypochromic anemia characterized by transfusion-dependent hypochromic, poorly regenerative anemia and iron overload, resembling non-syndromic sideroblastic anemia except for increased erythrocyte protoporphyrin levels.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0014094
- OMIM:615234
- UMLS:C3808920
Additional Mondo synonyms (3)
anemia, hypochromic microcytic, with iron overload type 2 · severe congenital hypochromic sideroblastic anaemia · severe congenital hypochromic sideroblastic anemia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Moderate — STEAP3
- LiteraturePresent
2 matched papers (0 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPartial
None under the specific name; 2114 for broader category anemia
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Probably — there is moderate evidence for STEAP3.
GenCC classification: Moderate.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
2
2 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
2 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
0 in the last 10 years · high confidence · 1.9th percentile (publications denominator)
Phrase hits: 2 · MeSH hits: 0
Who's working on it?
25
Distinct author names in 2 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Baños R1 paper · 2013Papers in Europe PMC
- 02Benítez J1 paper · 2013Papers in Europe PMC
- 03Bogliolo M1 paper · 2013
Genome Instability and DNA Repair Group, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
Papers in Europe PMC - 04Bueren JA1 paper · 2013Papers in Europe PMC
- 05Casado JA1 paper · 2013Papers in Europe PMC
- 06de Winter JP1 paper · 2013Papers in Europe PMC
- 07Derkunt B1 paper · 2013Papers in Europe PMC
- 08GU LIANQUAN1 paper · 2005Papers in Europe PMC
- 09HUANG SHILIANG1 paper · 2005Papers in Europe PMC
- 10HUANG ZHISHU1 paper · 2005Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial. 2,114 trials are registered for anemia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
2,114 interventional trials matched anemia, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: anemia
2,114
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06946394·NOT YET RECRUITING·Two Different Regiments of Pegmolesatide for Anemia in Patients With Chronic Kidney Disease Not Receiving Dialysis
Conditions: Renal Anemia in Non-dialysis Chronic Kidney Disease·Matched via name phrase
- NCT06742528·RECRUITING·Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
Conditions: Iron Deficiency Anemia · Iron Deficiency, Anaemia in Children·Matched via name phrase
- NCT07119372·RECRUITING·Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Conditions: Anemia · Chronic Kidney Disease · Chronic Kidney Disease Patients on Hemodialysis · Chronic Kidney Disease 5D·Matched via name phrase
- NCT07563582·RECRUITING·Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
Conditions: Celiac Disease in Children · Anemia · Iron Deficiencies·Matched via name phrase
- NCT06648096·RECRUITING·Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Conditions: Fanconi Anemia · Head and Neck Squamous Cell Carcinoma·Matched via name phrase
- NCT04869683·RECRUITING·Biocollection in MyeloDysplastic Syndrome (P-MDS)
Conditions: Myelodysplastic Syndromes · Myelodysplastic Anemia · Myelodysplastic Syndrome With Isolated Del(5Q) · Myelodysplastic Syndrome With Ring Sideroblasts·Matched via name phrase
- NCT07091370·NOT YET RECRUITING·Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy
Conditions: AIHA - Cold Autoimmune Hemolytic Anemia·Matched via name phrase
- NCT06124586·RECRUITING·Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Conditions: Diabetic Foot · Diabetes Mellitus · Peripheral Arterial Disease · Diabetic Neuropathies·Matched via name phrase
- NCT07441525·RECRUITING·UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
Conditions: Autoimmune Hemolytic Anemia · Primary Immune Thrombocytopenic Purpura · Evans Syndrome·Matched via name phrase
- NCT07038330·NOT YET RECRUITING·DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron
Conditions: Anemia·Matched via name phrase
- NCT07163390·NOT YET RECRUITING·Iron Deficiency Anemia in the Second and Third Trimester of Pregnancy
Conditions: Anemia, Iron Deficiency · Pregnancy Anemia·Matched via name phrase
- NCT07079579·NOT YET RECRUITING·Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients
Conditions: Renal Anemia in Non-dialysis Chronic Kidney Disease·Matched via name phrase
- NCT07569172·NOT YET RECRUITING·Improved Child Nutrition and Development Through Social Transfers
Conditions: Breastfeeding · Breastfeeding Education · Breastfeeding Duration · Breastfeeding Continuation·Matched via name phrase
- NCT06560164·RECRUITING·Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
Conditions: Transfusion · Red Blood Cell · Extracorporeal Membrane Oxygenation · Anemia·Matched via name phrase
- NCT06487299·NOT YET RECRUITING·Iron Administration Via Colonic TET Combined With WMT for ID
Conditions: Iron Deficiency Anemia in Childbirth·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06213402·RECRUITING·RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Conditions: Sickle Cell Disease · Thalassemia · Hemolytic; Anemia, Hereditary, Due to Enzyme Disorder · Anemia Due to Membrane Defect·Matched via recall expansion
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Severe congenital hypochromic anemia with ringed sideroblasts" OR "Severe congenital hypochromic sideroblastic anemia" OR "anemia, hypochromic microcytic, with iron overload type 2" OR "severe congenital hypochromic sideroblastic anaemia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Severe congenital hypochromic anemia with ringed sideroblasts" OR "Severe congenital hypochromic sideroblastic anemia" OR "anemia, hypochromic microcytic, with iron overload type 2" OR "severe congenital hypochromic sideroblastic anaemia" OR "STEAP3" OR "anemia, hypochromic microcytic with iron overload" OR "congenital anemia" OR "hereditary anemia"
Recall-expansion terms: STEAP3, anemia, hypochromic microcytic with iron overload, congenital anemia, hereditary anemia
Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"anemia"
Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T12:38:48.558Z
